NO20064834L - Forlenget frigivelse av sammensetninger som omfatter torasmid og en matriksdannende polymer. - Google Patents
Forlenget frigivelse av sammensetninger som omfatter torasmid og en matriksdannende polymer.Info
- Publication number
- NO20064834L NO20064834L NO20064834A NO20064834A NO20064834L NO 20064834 L NO20064834 L NO 20064834L NO 20064834 A NO20064834 A NO 20064834A NO 20064834 A NO20064834 A NO 20064834A NO 20064834 L NO20064834 L NO 20064834L
- Authority
- NO
- Norway
- Prior art keywords
- compositions
- torasmid
- forming polymer
- prolonged release
- matrix forming
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000011159 matrix material Substances 0.000 title 1
- 229920000642 polymer Polymers 0.000 title 1
- 230000002035 prolonged effect Effects 0.000 title 1
- 238000002360 preparation method Methods 0.000 abstract 2
- NGBFQHCMQULJNZ-UHFFFAOYSA-N Torsemide Chemical compound CC(C)NC(=O)NS(=O)(=O)C1=CN=CC=C1NC1=CC=CC(C)=C1 NGBFQHCMQULJNZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000002934 diuretic Substances 0.000 abstract 1
- 230000001882 diuretic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000013265 extended release Methods 0.000 abstract 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 abstract 1
- 229960005461 torasemide Drugs 0.000 abstract 1
- 230000002485 urinary effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Diuretiske preparater med forlenget frigivningsvirkning inneholdende torasemid som aktiv bestanddel. Preparatene ifølge oppfinnelsen er nyttige idet de gjør at plagsomme hyppige urinlatninger forårsaket av konvensjonelle preparater med umiddelbar frigivningsvirkning unngås.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200400740A ES2244324B1 (es) | 2004-03-25 | 2004-03-25 | Composiciones diureticas de liberacion prolongada. |
PCT/EP2005/051340 WO2005092291A1 (en) | 2004-03-25 | 2005-03-23 | Prolonged-release compositions comprising torasemide and a matrix-forming polymer |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20064834L true NO20064834L (no) | 2006-12-07 |
NO336582B1 NO336582B1 (no) | 2015-09-28 |
Family
ID=34962072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20064834A NO336582B1 (no) | 2004-03-25 | 2006-10-24 | Preparater med forlenget frigivning innbefattende torasemid, en matriksdannende polymer og laktose |
Country Status (20)
Country | Link |
---|---|
US (1) | US20080187585A1 (no) |
EP (1) | EP1732517B1 (no) |
JP (1) | JP4871258B2 (no) |
KR (1) | KR101203763B1 (no) |
CN (1) | CN1946379B (no) |
AR (1) | AR048432A1 (no) |
AU (1) | AU2005227095B2 (no) |
BR (1) | BRPI0509165A (no) |
CA (1) | CA2562142C (no) |
ES (2) | ES2244324B1 (no) |
MX (1) | MXPA06010833A (no) |
NO (1) | NO336582B1 (no) |
PA (1) | PA8627401A1 (no) |
PE (1) | PE20060015A1 (no) |
PL (1) | PL1732517T3 (no) |
PT (1) | PT1732517T (no) |
RU (2) | RU2006137671A (no) |
TW (1) | TWI351957B (no) |
UY (1) | UY28809A1 (no) |
WO (1) | WO2005092291A1 (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10596119B1 (en) * | 2018-11-08 | 2020-03-24 | Sarfez Pharmaceuticals, Inc. | Methods of treatment comprising torsemide |
WO2015050570A1 (en) * | 2013-10-06 | 2015-04-09 | Shah Salim | Controlled-release formulations comprising torsemide |
US10463622B2 (en) * | 2013-10-06 | 2019-11-05 | Sarfez Pharmaceuticals, Inc. | Treatments and formulations comprising Torsemide |
EP3031471A1 (en) * | 2014-12-12 | 2016-06-15 | Ceva Sante Animale | Veterinary composition for the treatment of pulmonary edema associated with heart failure in domestic animals |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3305935C2 (de) * | 1983-02-21 | 1985-05-30 | Medice Chem.-Pharm. Fabrik Pütter GmbH & Co KG, 5860 Iserlohn | Kaliumneutrales Saluretikum mit antihypertensiver Wirkung |
DE3529529A1 (de) * | 1985-08-17 | 1987-02-19 | Boehringer Mannheim Gmbh | Verfahren zur herstellung einer stabilen modifikation von torasemid |
GB8601204D0 (en) * | 1986-01-18 | 1986-02-19 | Boots Co Plc | Therapeutic agents |
JP3586471B2 (ja) * | 1991-06-25 | 2004-11-10 | 三菱ウェルファーマ株式会社 | トラセミド含有医薬組成物 |
DE19637082A1 (de) * | 1996-09-12 | 1998-03-19 | Boehringer Mannheim Gmbh | Schnellzerfallende Pellets |
GB9816899D0 (en) * | 1998-08-05 | 1998-09-30 | Boots Co Plc | Therapeutic agents |
US6465496B1 (en) * | 1999-08-11 | 2002-10-15 | Teva Pharmaceutical Industries, Ltd. | Torsemide polymorphs |
MXPA03007908A (es) * | 2000-02-17 | 2004-12-06 | Teva Pharma | Una formulacion farmaceutica estable que comprende una modificacion de torsemida ii. |
DE10013289A1 (de) * | 2000-03-17 | 2001-09-20 | Knoll Ag | Torasemid enthaltende pharmazeutische Zubereitungen |
US20030119882A1 (en) * | 2001-10-22 | 2003-06-26 | Markus Maegerlein | Solid pharmaceutical composition containing torasemide |
US20030104052A1 (en) * | 2001-10-25 | 2003-06-05 | Bret Berner | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
US20030091630A1 (en) * | 2001-10-25 | 2003-05-15 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
US20030152622A1 (en) * | 2001-10-25 | 2003-08-14 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral diuretic |
US6863901B2 (en) * | 2001-11-30 | 2005-03-08 | Collegium Pharmaceutical, Inc. | Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
HRP20020124A2 (en) * | 2002-02-11 | 2003-10-31 | Pliva D D | Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping |
CA2548387A1 (en) * | 2003-12-12 | 2005-06-30 | Penwest Pharmaceuticals Co. | Sustained release torsemide dosage forms |
-
2004
- 2004-03-25 ES ES200400740A patent/ES2244324B1/es not_active Expired - Lifetime
-
2005
- 2005-03-09 PE PE2005000267A patent/PE20060015A1/es active IP Right Grant
- 2005-03-14 UY UY28809A patent/UY28809A1/es unknown
- 2005-03-16 AR ARP050101017A patent/AR048432A1/es not_active Application Discontinuation
- 2005-03-18 TW TW094108282A patent/TWI351957B/zh not_active IP Right Cessation
- 2005-03-23 US US10/594,004 patent/US20080187585A1/en not_active Abandoned
- 2005-03-23 PT PT57171332T patent/PT1732517T/pt unknown
- 2005-03-23 RU RU2006137671/15A patent/RU2006137671A/ru unknown
- 2005-03-23 MX MXPA06010833A patent/MXPA06010833A/es active IP Right Grant
- 2005-03-23 JP JP2007504420A patent/JP4871258B2/ja not_active Expired - Fee Related
- 2005-03-23 EP EP05717133.2A patent/EP1732517B1/en active Active
- 2005-03-23 ES ES05717133.2T patent/ES2632354T3/es active Active
- 2005-03-23 AU AU2005227095A patent/AU2005227095B2/en not_active Ceased
- 2005-03-23 CN CN2005800093895A patent/CN1946379B/zh not_active Expired - Fee Related
- 2005-03-23 PL PL05717133T patent/PL1732517T3/pl unknown
- 2005-03-23 CA CA2562142A patent/CA2562142C/en active Active
- 2005-03-23 BR BRPI0509165-9A patent/BRPI0509165A/pt not_active Application Discontinuation
- 2005-03-23 KR KR1020067021596A patent/KR101203763B1/ko active IP Right Grant
- 2005-03-23 WO PCT/EP2005/051340 patent/WO2005092291A1/en active Application Filing
- 2005-03-24 PA PA20058627401A patent/PA8627401A1/es unknown
-
2006
- 2006-10-24 NO NO20064834A patent/NO336582B1/no not_active IP Right Cessation
-
2010
- 2010-11-03 RU RU2010145009/15A patent/RU2449778C1/ru active
Also Published As
Publication number | Publication date |
---|---|
JP4871258B2 (ja) | 2012-02-08 |
PA8627401A1 (es) | 2005-11-25 |
PL1732517T3 (pl) | 2017-09-29 |
TWI351957B (en) | 2011-11-11 |
PT1732517T (pt) | 2017-08-03 |
NO336582B1 (no) | 2015-09-28 |
EP1732517A1 (en) | 2006-12-20 |
JP2007530510A (ja) | 2007-11-01 |
EP1732517B1 (en) | 2017-05-03 |
AR048432A1 (es) | 2006-04-26 |
TW200531693A (en) | 2005-10-01 |
WO2005092291A1 (en) | 2005-10-06 |
US20080187585A1 (en) | 2008-08-07 |
BRPI0509165A (pt) | 2007-09-11 |
RU2449778C1 (ru) | 2012-05-10 |
KR20060130756A (ko) | 2006-12-19 |
KR101203763B1 (ko) | 2012-11-23 |
ES2632354T3 (es) | 2017-09-12 |
ES2244324B1 (es) | 2006-11-16 |
ES2244324A1 (es) | 2005-12-01 |
CN1946379B (zh) | 2012-05-16 |
MXPA06010833A (es) | 2006-12-15 |
AU2005227095A1 (en) | 2005-10-06 |
RU2006137671A (ru) | 2008-04-27 |
PE20060015A1 (es) | 2006-02-02 |
AU2005227095B2 (en) | 2010-10-28 |
CA2562142A1 (en) | 2005-10-06 |
CA2562142C (en) | 2012-06-05 |
CN1946379A (zh) | 2007-04-11 |
UY28809A1 (es) | 2005-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS51569B (en) | COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL | |
DE602006002260D1 (de) | Insektenabweisende zusammensetzungen mit verzögerter freisetzung | |
NO20091395L (no) | Nye tiofenderivater | |
HRP20080564T3 (en) | Dihydrotetrabenazines and pharmaceutical compositions containing them | |
SG153800A1 (en) | Pharmaceutical compositions | |
TW200700406A (en) | Novel thiophene derivatives | |
ATE447568T1 (de) | Neue pyrinderivate | |
TW200708511A (en) | Novel thiophene derivatives | |
TW200716552A (en) | Novel thiophene derivatives | |
BRPI0715579A2 (pt) | "composto, composição farmacêutica e uso de um composto" | |
RS52169B (en) | STABLE LAKVINIMOD PREPARATIONS | |
GEP20135803B (en) | Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives | |
MY154909A (en) | Novel thiophene derivatives | |
TW200716628A (en) | Novel compounds | |
EA200801083A1 (ru) | Новые производные дигидропсевдоэритромицина | |
MX2010005889A (es) | Derivados de tiofeno como agonistas de s1p1/edg1. | |
MA28999B1 (fr) | Compositions destinees a lutter contre un ou plusieurs pathogenes | |
RS50510B (sr) | Formulacije koje sadrže ekteinascidin i disaharid | |
DK1792927T3 (da) | Ny blokcopolymer, micelletilberedning og anticancermiddel indeholdende samme som aktiv ingrediens | |
NO20071095L (no) | Hittil ukjente tiofenderivater | |
PT1401501E (pt) | Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo | |
WO2008006528A3 (en) | Pharmaceutical compositions comprising levetiracetam | |
EA200901393A1 (ru) | Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат | |
ATE354362T1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff | |
BR0313385A (pt) | Derivados de pirimidina-2,4-diona como inibidores de metaloproteinase da matriz |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |